This is archived HHS content.
Skip to main content
HHS
.gov
Search
U.S. Department of Health & Human Services
Search
Close
A-Z Index
About HHS
Programs & Services
Grants & Contracts
Laws & Regulations
Home
>
Blog
> Categories > Drug Pricing
Text Resize
A
A
A
Print
Share
Categories
Coronavirus (9)
Drug Pricing (12)
Emergency Preparedness and Response (11)
Fraud (2)
Global Health (11)
Grants and Contracts (4)
Health Data (2)
Health Insurance Reform (4)
Health IT (6)
HHS Administrative (29)
Holidays and Observances (19)
Medicare and Medicaid (1)
Mental Health and Substance Abuse (9)
Opioids (17)
Prevention and Wellness (42)
Programs for Families and Children (30)
Public Health and Safety (37)
Research (20)
Telehealth (1)
Value-Based Care (2)
Category: Drug Pricing
Why Putting List Prices in Drug Ads Matters
May 17, 2019
By:
John O’Brien
, Senior Advisor to the Secretary for Drug Pricing Reform
Posted In:
Drug Pricing
Tagged:
prescription drugs
|
list price
|
patients
Patients need transparency and relief from high drug costs, not defense of the status quo
March 11, 2019
By:
John O’Brien
, Senior Advisor to the Secretary for Drug Pricing Reform
Posted In:
Drug Pricing
Tagged:
prescription drugs
How the IPI Model Would Introduce New Market Competition to Medicare Drug Spending
December 6, 2018
By:
John O’Brien
, Senior Advisor to the Secretary for Drug Pricing Reform
Posted In:
Drug Pricing
Tagged:
Medicare
|
Part B
|
prescription drugs
Proposed Changes to Lower Drug Prices in Medicare Advantage and Part D
November 26, 2018
By:
Alex M. Azar II
, Secretary of the Department of Health and Human Services and
Seema Verma
, Administrator of the Centers for Medicare & Medicaid Services
Posted In:
Drug Pricing
Tagged:
Medicare
|
prescription drugs
|
Part D
|
beneficiaries
Answering Your Questions about the IPI Drug Pricing Model
October 30, 2018
By:
Dan Best
, Senior Advisor to the Secretary for Drug Pricing Reform
Posted In:
Drug Pricing
Tagged:
Medicare
|
prescription drugs
What the Media Is Missing on Drug Pricing
July 18, 2018
By:
Dan Best
, Senior Advisor to the Secretary for Drug Pricing Reform
Posted In:
Drug Pricing
Tagged:
American Patients First
|
blueprint
|
pharmaceutical companies
My Mother Died of Alzheimer’s – We Need to find an Affordable and Effective Treatment
May 23, 2018
By:
Suzanne Wronsky
, Potomac, Maryland
Posted In:
Drug Pricing
Tagged:
patients
|
prescriptions
|
Medication
Living with a Kidney Transplant and the High Cost of Drugs to Maintain It
May 22, 2018
By:
Richard Knight
, New Carrollton, Maryland
Posted In:
Drug Pricing
Tagged:
patients
|
prescriptions
|
Medication
I’m a Breast Cancer Survivor, but a Costly Drug Put My Retirement at Risk
May 21, 2018
By:
Janet Flynn
, Falls Church, Virginia
Posted In:
Drug Pricing
Tagged:
patients
|
Medication
|
Prescription
I Won’t Go Into Debt Even Though I Can’t Otherwise Afford My “Wonder Drug”
May 18, 2018
By:
Sue Lee
, Crestwood, Kentucky
Posted In:
Drug Pricing
Tagged:
patients
|
prescriptions
|
Medication
Pages
of 2
>
Sign Up For Blog Updates
Enter your email:
Subscribe to RSS
Receive latest updates
Back to
T
op
This is archived HHS content.